ICH E6(R3) Demystified: What It Means for You

As clinical trials evolve globally, the new ICH E6(R3) guidelines represent a critical shift for sponsors, sites, CROs, and vendors. In this on-demand webinar, clinical research professionals gained actionable insights into what ICH E6(R3) means for their day-to-day operations and long-term compliance strategies.

This session is essential for clinical operations, regulatory, quality, and compliance teams preparing for the future of GCP.

In this webinar, you will learn:

• Which countries contributed to the development of ICH E6(R3) and when broader adoption is expected
• What’s new in R3, including expanded expectations for computerized systems and data governance
• What sponsors, sites, and service providers (like CROs and tech vendors) are now responsible for under the updated guidelines
• How to prepare for increased oversight, collaboration, and risk management expectations across all stakeholders

With participation from all over the world, it’s clear that the industry is actively seeking clear and practical guidance on the revised framework. Although ICH E6(R3) has only been adopted in the EU so far, it is already being recognized as the emerging international standard.